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The prognosis of hepatocellular carcinoma (HCC), 
which is diagnosed in over 500,000 people worldwide 
annually, remains dismal despite advances in its clini-
cal study [1, 2]. HCC is much more common in count-
ries in sub-Saharan Africa and Southeast Asia than 
in the United States, ranking among the most common 
type of cancer in these regions, and is more common 
in men than in women [1]. In the U.S., liver and intrahe-
patic bile duct cancers incidence has been stable and 
results in 4% of cancer deaths in men and 2% of cancer 
deaths in women [2]. Average age at diagnosis for 
liver cancer is 64 and over 90% of people diagnosed 
with liver cancer are older than 45 years of age [1]. 
Hepatitis B and C, abuse of alcohol, and exposure 
to aflatoxin are the most important etiological factors 
implicated in HCC.
The most prevalent causes of death in patients with 
HCC include uncontrolled metastasis and recurrence. 
In recent years, efforts have been focused on exploring 
many molecular markers related to invasion, metas-
tasis, recurrence and survival in HCC: DNA ploidy, the 
proliferating activity of tumor cells, tumor suppressor 
and promoter genes, cell cycle controllers, protein-
ases that degrade extracellular matrix, adhesion mo-
lecules, angiogenic factors and metabolic genes [3]. 
Among these factors, the matrix metalloproteinases 
(MMPs) and the plasminogen activation system play 
crucial roles in cancer invasion and metastasis. Levels 
of MMP expression were found correlated to recur-
rence and reduced survival after HCC resection [4, 5].
MMPs are a family of zinc and calcium dependent 
proteolytic enzymes, are able to degrade connective 
tissue, among other substrates, such as basement 
membrane collagen, and have been associated with 
cancer metastasis and tumor angiogenesis. The 
gelatinases, especially MMP-9 (gelatinase B) and 
MMP-2 (gelatinase A), play a key role in degradation 
of collagen type IV, a main component of the extracel-
lular matrix (ECM). These gelatinases are expressed 
in hepatocellular carcinoma cells and are associated 
with progression and invasion of these tumors [4, 6–9]. 
For example, Guo et al. [9] noted positive correlation of 
MMP-9, MMP-2 and vascular endothelial growth factor 
(VEGF) expression with recurrence of HCC. 
Rath and Pauling [10] postulated that nutrients 
such as lysine and ascorbic acid could act as natural 
inhibitors of ECM proteolysis and, as such, have the 
potential to modulate tumor growth and expansion. 
These nutrients can exercise their anti-tumor effect 
through the inhibition of MMPs and by strengthening 
connective tissue surrounding cancer cells by influ-
encing collagen synthesis. These two processes are 
essential for a tumor encapsulating effect. We have 
developed strategies to inhibit cancer development 
and its spread using naturally occurring nutrients such 
as lysine, proline, ascorbic acid and green tea extract 
(NM). This nutrient mixture has exhibited synergistic 
anticancer activity in vivo and in vitro in a number 
of cancer cell lines through inhibition of cancer cell 
growth, MMP secretion, invasion, metastasis, and 
angiogenesis [11–13]. The present study examines the 
effect of NM on human HCC cell line SK-Hep-1, in vivo, 
in athymic nude mice bearing SK-Hep-1 xenografts, 
and in vitro, evaluating viability, MMP secretion, inva-
sion and induction of apoptosis. 
We designed NM by defining critical physiological 
targets in cancer progression and metastasis, such 
as ECM integrity and MMP activity. ECM formation 
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and structure is dependent upon adequate supplies 
of ascorbic acid and the amino acids lysine and proline, 
which insure proper synthesis and hydroxylation of col-
lagen fibers. Manganese and copper are also essen-
tial for collagen formation. Lysine, a natural inhibitor 
of plasmin-induced proteolysis, plays an important role 
in ECM stability [10, 14]. Green tea extract has been 
shown to modulate cancer cell growth, metastasis, 
angiogenesis, and other aspects of cancer progres-
sion [15–19]. N-acetyl cysteine has been observed to 
inhibit MMP-9 activity [20] and invasive activities of 
tumor cells [21]. Selenium has been shown to interfere 
with MMP secretion and tumor invasion [22], as well as 
migration of endothelial cells through ECM [21]. In ad-
dition to addressing ECM properties, some nutrients 
are critical in inducing cancer cell death. A recent study 
confirmed that ascorbic acid inhibits cell division and 
growth through production of hydrogen peroxide [23].  
Since arginine is a precursor of nitric oxide (NO), any 
deficiency of arginine can limit the production of NO, 
which has been shown to predominantly act as an 
inducer of apoptosis, as in breast cancer cells [24].
MATERIALS AND METHODS 
Cancer cell line and culture. Human hepatoma 
cell line SK-Hep-1 was obtained from ATCC (American 
Type Culture Collection, Rockville, MD). SK-Hep-1 
cells were maintained in minimum essential medium 
(MEM) supplemented with 10% fetal bovine serum, 
100 U/ml penicillin and 100 μg/ml streptomycin. The 
media and sera used were obtained from ATCC, and 
antibiotics (penicillin and streptomycin) were from 
Gibco BRL, Long Island, NY.
Composition of the nutrient mixture. The nutrient 
mixture (NM) was composed of the following in the 
ratio indicated: Vitamin C (as ascorbic acid and as 
Mg, Ca, and palmitate ascorbate) 700 mg; L-lysine 
1000 mg; L-proline 750 mg; L-arginine 500 mg; 
N-acetyl cysteine 200 mg; standardized green tea 
extract (derived from green tea leaves, was obtained 
from US Pharma Lab; the certificate of analysis indi-
cated the following characteristics: total polyphenol 
80%, catechins 60%, epigallocatechin gallate (EGCG) 
35%, and caffeine 1.0%); 1000 mg; selenium 30 μg; 
copper 2 mg; manganese 1 mg. 
IN VIVO STUDIES
Animals. Male athymic mice (NCr-nu/nu), approxi-
mately five weeks of age on arrival, were purchased 
from Simonsen Laboratories, Gilroy, CA and main-
tained in microisolator cages under pathogen-free 
conditions on a 12-hour light/12-hour dark schedule 
for a week. All procedures were performed according 
to humane and customary care and use of experi-
mental animals and followed a protocol approved by 
internal institutional animal safety review committee. 
Experimental design. After housing for a week, 
the mice (n = 12) were inoculated subcutaneously 
with 3 x 106 SK-Hep-1 cells in 0.2 ml PBS and 0.1 ml 
Matrigel (BD Bioscience, Bedford, MA). After injec-
tion, the mice were randomly divided into two groups; 
group A mice were fed regular Purina mouse chow and 
group B the regular diet supplemented with 0.5% NM 
(w/w). During the study, the mice consumed, on the 
average, 4 g of their respective diets per day. Thus, 
the supplemented mice received approximately 20 mg 
of NM per day. After four weeks, the mice were sac-
rificed and their tumors were excised and processed 
for histology. Dimensions (length and width) of tumors 
were measured using a digital caliper, and the tumor 
burden was calculated using the following formula: 
0.5 x length x width. Mean weight of mice at initiation 
of study and termination of study did not differ signifi-
cantly between the groups.
Histology. Tissue samples were fixed in 10% 
buffe red formalin. All tissues were embedded in pa-
raffin and cut at 4–5 microns. Sections were deparaf-
finized through xylene and graduated alcohol series to 
water and stained with hematoxylin and eosin (H&E) for 
evaluation using a standard light microscope.
IN VITRO STUDIES
Cell culture. Human SK-Hep-1 cells were grown 
in MEM, supplemented with 10% fetal bovine serum, 
penicillin (100 U/ml) and streptomycin (100 mg/ml) 
in 24-well tissue culture plates (Costar, Cambridge, 
MA). Cells were incubated with 1 ml of media at 37 °C 
in a tissue culture incubator equilibrated with 95% air 
and 5% CO2. At near confluence, the cells were treated 
with the nutrient mixture, dissolved in media and tested 
at 0, 10, 50, 100, 500, and 1000 μg/ml in triplicate at 
each dose. Phorbol 12-myristate 13-acetate (PMA), 
100 ng/ml was added to cells to induce MMP-9 secre-
tion. The plates were then returned to the incubator. 
MTT assay. Cell viability was evaluated by MTT 
assay, a colorimetric assay based on the ability of 
viable cells to reduce a soluble yellow tetrazolium 
salt [3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetra-
zolium bromide] (MTT) to a blue formazan crystal by 
mitochondrial succinate dehydrogenase activity of 
viable cells. This test is a good index of mitochondrial 
activity and thus of cell viability. After 24 h incubation, 
the cells were washed with phosphate buffered saline 
(PBS) and 500 μl of MTT (Sigma #M-2128) 0.5 mg/ml 
in media was added to each well. After MTT addition 
(0.5 mg/ml) the plates were covered and returned 
to the 37 °C incubator for 2 h, the optimal time for 
formazan product formation. Following incubation, the 
supernatant was carefully removed from the wells, the 
formazan product was dissolved in 1 ml DMSO, and 
absorbance was measured at 570 nm in Bio Spec 1601, 
Shimadzu spectrometer. The OD570 of the DMSO solu-
tion in each well was considered to be proportional to 
the number of cells. The OD570 of the control (treatment 
without supplement) was considered 100%. 
Gelatinase zymography. Gelatinase zymography 
was performed in 10% Novex Pre-Cast SDS Polyacryla-
mide Gel (Invitrogen Corporation) in the presence of 
0.1% gelatin under non-reducing conditions. Culture 
media (20 mL) were mixed with sample buffer and 
loaded for SDS-PAGE with tris glycine SDS buffer, 
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as suggested by the manufacturer (Novex). Samples 
were not boiled before electrophoresis. Following 
electrophoresis the gels were washed twice in 2.5% 
Triton X-100 for 30 min at room temperature to remove 
SDS. The gels were then incubated at 37 °C overnight in 
substrate buffer containing 50 mM Tris-HCl and 10 mM 
CaCl2 at pH 8.0 and stained with 0.5% Coomassie Blue 
R250 in 50% methanol and 10% glacial acetic acid for 
30 min and destained. Upon renaturation of the en-
zyme, the gelatinases digested the gelatin in the gel, 
producing clear bands against an intensely stained 
background. Protein standards were run concurrently 
and approximate molecular weights were determined 
by plotting the relative mobilities of known proteins.
Matrigel invasion. Invasion studies were con-
ducted using Matrigel (Becton Dickinson) inserts in 
24-well plates. Suspended in medium, SK-Hep-1 cells 
were supplemented with nutrients, as specified in the 
design of the experiment and seeded on the insert in 
the well. Thus both the medium on the insert and in the 
well contained the same supplements. The plates with 
the inserts were then incubated in a culture incubator 
equilibrated with 95% air and 5% CO2 for 24 h. After 
incubation, the media from the wells were withdrawn. 
The cells on the upper surface of the inserts were 
gently scrubbed away with cotton swabs. The cells that 
had penetrated the Matrigel membrane and migrated 
onto the lower surface of the Matrigel were stained with 
hematoxylin and eosin and visually counted under the 
microscope.
Morphology and apoptosis. Morphology of cells 
cultured for 24 h in test concentrations of NM were 
evaluated by H&E staining and observed and photo-
graphed by microscopy. At near confluence, SK-Hep-1 
cells were challenged with NM dissolved in media at 0, 
100, 500, and 1000 μg/ml and incubated for 24 h. The 
cell culture was washed with PBS and treated with the 
caspase reagent as specified in the manufacturer’s 
protocol (Molecular Probes Image-IT™ Live Green Poly 
Caspases Detection Kit 135104, Invitrogen). The cells 
were photographed under a fluorescence microscope 
and counted. Green-colored cells represent viable 
cells, while yellow orange represents early apoptosis 
and red late apoptosis
Statistical analysis. The results were expressed as 
means ± SD, as indicated in the results, for the groups. 
Data was analyzed by independent sample “t” test. 
Pearson’s correlation coefficients were determined for 
toxicity and invasion correlations to NM concentration 
using MedCalc Software (Markakerke, Belgium).
RESULTS
IN VIVO STUDIES
Tumor growth and incidence. NM strongly inhi-
bited the growth and incidence of SK-Hep-1 xenografts 
in nude mice. Mean tumor weight was inhibited by 42% 
(p = 0.09) with NM 0.5% dietary supplementation, as 
shown in Fig. 1, a and tumor burden was inhibited by 
36% (p = 0.005), as shown in Fig. 1, b. Tumor incidence 
decreased 33% with NM supplementation; all mice in 
the control group developed tumors, while only 4 of 
6 mice did on the supplemented diet. Representative 
gross tumors from both groups are shown in Fig. 2.
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Fig. 1. a, effect of NM on mean tumor weight of SK-Hep-1 
xenografts in male nude mice inoculated subcutaneously with 
3 x 106 SK-Hep-1 cells. Each group was composed of 6 animals. 
b, effect of NM on tumor burden of SK-Hep-1 xenografts in male 
nude mice inoculated subcutaneously with 3 x 106 SK-Hep-1 
cells. Each group was composed of 6 animals. *Indicates sig-
nificance of p = 0.005 with respect to control.
Control Group
NM-Group
Fig. 2. Gross tumors from male nude mice inoculated subcuta-
neously with 3 x 106 SK-Hep-1 cells. Each group was composed 
of 6 animals. All mice in the control group developed tumors while only 
4 of the 6 mice in the NM-supplemented group developed tumors
Histology. Histologically, the tumors from both 
groups were composed of solid nests of irregularly 
round to oval epithelioid cells with large irregularly 
round nuclei and cytoplasm with indistinct borders. 
Stromal spindle-shaped cells that were intermixed 
with inflammatory cells, predominantly macrophages, 
surrounded tumor nests, as well as the tumor masses. 
Focal areas of necrosis involved about 30% of the 
tumor tissue (Fig. 3, a–d).
IN VITRO STUDIES
Cytotoxicity. NM exhibited no toxicity to SK-Hep-1 
cells in vitro at lower concentrations, but 33% 
(p = 0.002) toxicity over control at 500 and 1000 μg/ml, 
as shown in Fig. 4. There was significant negative cor-
relation between NM concentration and cell viability, 
with coefficient r = –0.8622 (p < 0.0001).
Experimental Oncology 32, 84–91, 2010 (June) 87
0
20
40
60
80
100
120
140
Control NM
10 μg/ml 
NM
50 μg/ml 
NM
100 μg/ml 
NM
500 μg/ml 
NM
1000 μg/ml 
Ce
ll 
Pr
ol
ife
ra
tio
n,
 %
 o
f C
on
tro
l
* *
Fig. 4. Effect of NM on viability of SK-Hep-1 cells: MTT 24 h 
assay performed in triplicates. *Indicates significance of at least 
p = 0.002 with respect to control.
Gelatinase zymography. Zymography demon-
strated MMP-2 and MMP-9 secretion by normal and 
PMA-treated SK-Hep-1 cells. NM inhibited secretion 
of both MMPS in a dose-dependent fashion with virtual 
total inhibition at 1000 μg/ml, as shown in Fig. 5, a–d.
Matrigel invasion. NM significantly inhibited SK-
Hep-1 invasion through Matrigel in a dose-dependent 
manner, with 53% (p = 0.0001) inhibition at 100 μg/ml, 
83% at 500 μg/ml (p < 0.0001) and 100% (p < 0.0001) 
at 1000 μg/ml, as shown in Fig. 6 and Fig. 7, a–f. There 
was significant negative correlation between NM con-
centration and number of SK-Hep-1 cells that invaded/
migrated through Matrigel: r = –0.8533, p < 0.0001.
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Fig. 3. Histopathology of tumors: a, control (100X); b, control (400X); c, NM-supplemented (100X); d, NM-supplemented (400X)
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Fig. 5. Effect of NM on SK-Hep-1 cell MMP-2 and MMP-9 secretion (a) and on PMA (100 ng/ml)-treated SK-Hep-1 cell MMP-2 
and MMP-9 secretion (b). 1 — markers, 2 — control, 3–7 — NM 10, 50, 100, 500, 1000 μg/ml. Densitometry analysis of untreated 
SK-Hep-1 cells (c) and PMA-treated SK-Hep-1 cells (d)
88 Experimental Oncology 32, 84–91, 2010 (June)
0
20
40
60
80
100
120
Control NM
10 μg/ml 
NM
50 μg/ml 
NM
100 μg/ml 
NM
500 μg/ml 
NM
1000 μg/ml 
In
hi
bi
tio
n 
of
 In
va
si
on
, %
* *
*
*
*
Fig. 6. Effect of NM on Matrigel invasion of SK-Hep-1 cells per-
formed in triplicate. *Indicates significance of at least p = 0.001 
with respect to control.
Morphology and apoptosis. H&E staining 
showed no morphological changes at lower con-
centrations but revealed significant changes at the 
higher concentrations of NM, as shown in Fig. 8, a–d. 
Using the live green caspase kit, dose-dependent 
apoptosis of SK-Hep-1 cells was evident with NM 
challenge, as shown in Fig. 9, a–d. Approximately 16% 
of cells exposed to 100 μg/ml NM were apoptotic; the 
number of apoptotic cells increased significantly with 
increased NM concentration. Quantitative analysis of 
live, early and late apoptotic cells is shown in Fig. 10. At 
100 μg/ml NM, 84% of cells were viable, 15% in early 
apoptosis and 1% in late apoptosis and at 500 μg/ml 
NM < 1% of cells were viable, 5% in early apoptosis, 
and 95% in late apoptosis. Virtually all cells exposed 
to 1000 μg/ml NM were in late apoptosis: < 1% viable, 
2% in early apoptosis and 97% in late apoptosis.
DISCUSSION
The results of the in vivo study of human SK-Hep-1 
xenografts in immune impaired (athymic) male nude 
mice demonstrated significant suppression of SK-Hep-1 
tumor growth (42% reduction in tumor weight and 36% 
in tumor burden) with NM dietary supplementation. Re-
sults from the cellular proliferation and apoptosis studies 
support the in vivo findings, as NM showed increased 
toxicity in SK-Hep-1 cells with NM concentration and in-
a b
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e f
Fig. 7. Effect of NM on Matrigel invasion, photomicrographs: a, control; b, NM 10 μg/ml; c, NM 50 μg/ml; d, NM 100 μg/ml; e, NM 
500 μg/ml; f, NM 1000 μg/ml
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duced apoptosis in SK-Hep-1 cells in a dose-dependent 
manner, with 33% inhibition of cell growth and apoptotic 
induction of virtually all cells exposed to 500 μg/ml NM.
Tumor growth depends upon the generation of new 
blood vessels to sustain cellular survival and proliferation. 
Growing tumors become hypoxic and acidotic beyond the 
size of 2 mm and secrete seve ral growth factors to stimu-
late local blood vessels to sprout branches. Activation of 
endothelial cells leads to production of matrix metallopro-
teinases, enabling degradation of the surrounding extra-
cellular matrix and eventual development of new blood 
vessels. In a previous study, NM significantly (p < 0.05) 
reduced bFGF-induced angiogenesis (utilizing a chorioal-
lantoic membrane (CAM) assay in chick embryos, as well 
as decreased human osteosarcoma U2OS cell expression 
of VEGF, angiopoietin-2, bFGF, PDGF and TGFb-1 [11]. 
Invasion of host tissues is dependent on tumor cell 
adhesion, cell migration, and proteolytic degradation 
of the ECM by MMPs [25]. As mentioned previously, 
MMPs, especially MMP-2 and MMP-9 are prognostic 
for survival and metastatic potential in liver cancers. 
Määtä et al. [6] found that MMP-2 and MMP-9 were 
elevated in malignant tissue and that increased latent 
and active MMP-2 levels predominantly were found in 
tumor stroma while MMP-9 was primarily found in the 
neoplastic epithelial cells. Furthermore, elevated MMP-2 
and MMP-9 mRNA was associated with a tendency to 
poorer survival of patients. In examination of gelatinolytic 
activity in tissues of HCC patients, Sakamoto et al. [4] 
found that overexpression of MMP-9 mRNA correlated 
with growth of small hepatocellular carcinoma. In examin-
ing the expression of apoptotic and angiogenic factors 
in a group of patients with HCC, Guo et al. [9] found that 
expression of MMP-9, MMP-2 and VEGF levels positively 
correlated with prognosis of HCC patients, specifically 
with recurrence. Jiang et al. [5] found that high MMP-9, 
but not VEGF expression, correlated with recurrence 
or metastasis of HCC in patients post hepatectomy. In 
our study, MMP-2 and MMP-9 secretion and Matrigel 
invasion by SK-Hep-1 cells was inhibited by NM in a 
dose-dependent manner with virtual total block of MMP 
secretion and invasion at 1000 μg/ml. 
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Fig. 8. Effect of NM on morphology of SK-Hep-1 cells: a, control; b, NM 10 μg/ml; c, NM 50 μg/ml; d, NM 100 μg/ml; e, NM 
500 μg/ml; f, NM 1000 μg/ml. H&E staining
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Fig. 10. Quantitative analysis of live, early and late apoptotic cells
The relative stability of extracellular matrix plays 
a key role in the development of cancer. We have 
previously shown that the ECM synthesized by normal 
fibroblasts treated with NM demonstrated increased 
stability and significantly reduced osteosarcoma cell 
growth rate, invasive activity (MMP-2 and MMP-9 
secretion and Matrigel invasion), and adhesion to 
collagen I and other substrates, suppressing tumor 
growth independent of the immune system function 
and inhibiting critical steps in cancer metastasis [12]. 
CONCLUSIONS
The results of the present study show that supple-
mentation with NM was effective in inhibiting growth 
of SK-Hep-1 xenografts in nude mice and in inhibiting 
growth, MMP secretion, and Matrigel invasion as well 
as inducing apoptosis in SK-Hep-1 cell culture. Fur-
thermore, in contrast to the toxic side effects of current 
chemotherapy, the nutrient mixture has been shown 
to be a safe therapeutic agent. In a previous in vivo 
study addressing safety issues, we found that gavag-
ing adult female ODS rats (weighing 250–300 gm) 
with the nutrient mixture (at 30, 90 or 150 mg per day 
for seven days), had neither adverse effects on vital 
organs (heart, liver and kidney), nor on the associated 
functional serum enzymes, indicating that this mixture 
is safe to use even at these high doses, which far 
exceed the normal equivalent dosage of the nutrient. 
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